Comparison of the effect of the carcinogen N-hydroxy-N-2-fluorenylacetamide in infant and weanling rats.
D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001835:Body Weight; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced; D004032:Diet; D004428:Ear Neoplasms / Q000139:chemically induced; D005260:Female; D005449:Fluorenes; D007417:Intestinal Polyps / Q000139:chemically induced; D007441:Intubation, Gastrointestinal; D008113:Liver Neoplasms / Q000139:chemically induced; D008175:Lung Neoplasms / Q000139:chemically induced; D008297:Male; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D010212:Papilloma / Q000139:chemically induced; D051381:Rats; D012509:Sarcoma / Q000139:chemically induced; D013274:Stomach Neoplasms / Q000139:chemically induced; D013997:Time Factors; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced
D005449:Fluorenes